HILARI R HEAD
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family COOPERSTOWN, NY NPI 1073009585
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Astellas Pharma US Inc All categories
General Payments — all program years on this page
$887.31
- Category: General Payments
- Program years: PY2024
- Record count: 35
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $887.31 across 35 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $697.33 | 33 |
| Education | $189.98 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $235.33 | 4 |
| GENZYME CORPORATION | $80.28 | 3 |
| Janssen Biotech, Inc. | $69.91 | 2 |
| EISAI INC. | $61.81 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $61.38 | 4 |
| Acerta Pharma LLC | $59.89 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.93 | 2 |
| Incyte Corporation | $35.13 | 2 |
| PFIZER INC. | $30.04 | 2 |
| Regeneron Healthcare Solutions, Inc. | $27.94 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.57 | 1 |
| Karyopharm Therapeutics Inc. | $24.88 | 1 |
| Coherus Biosciences Inc. | $21.14 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.03 | 1 |
| Genmab U.S., Inc. | $20.00 | 1 |
| Genentech USA, Inc. | $19.31 | 1 |
| ARRAY BIOPHARMA INC | $17.44 | 1 |
| SpringWorks Therapeutics, Inc. | $16.36 | 1 |
| Celgene Corporation | $13.94 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $887.31 | 35 |
Records — PY2024 (35)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.